retatrutide pcos FOR WOMEN: on GLP-1 Weight Loss #retatrutide #glp1 #pcos RETATRUTIDE FOR WOMEN: PCOS on

In a phase 2 clinical trial, CagriSema reduced HbA1c by 2.2% (p = 0.075) in comparison with semaglutide 2.4 mg alone [101]

The same logic applies to Retatrutide

GLP-1 therapy has been linked to improved inflammatory markers (like Hs-CRP), metabolic markers (like HbA1C), and lipid/cholesterol markers (like HDL and LDL)

The goal is to support gradual, medically guided weight loss while helping clients build healthier routines

GLP-1 is a hormone your body already uses to help regulate hunger and satiety

[DOI] [PubMed] [Google Scholar] 38.Green J.B., Hernandez A.F., DAgostino R.B., Granger C.B., Janmohamed S., Jones N.P., Leiter L.A., Noronha D., Russell R., Sigmon K., et al